Boston Scientific (NYSE:BSX) today announced the commercial launch of its Polaris imaging software, an upgrade to the company’s iLab system that aims to make intravascular imaging simpler and more powerful.
Medical device maker St. Jude Medical (NYSE:STJ) won CE Mark approval in the European Union for its ViewFlex Xtra intracardiac echocardiography catheter for use with the device giant’s ViewMate Z ultrasound console.
The upgraded system offers one-handed use, an ergonomic handle and 4-way tip deflection, according to a press release.
International Cardio Corp. is licensing a noninvasive technology from the University of Minnesota that uses high-intensity focused ultrasound energy to treat clogged arteries.
Company president Donald Knight has a brother who nearly died during an angioplasty procedure, according to the company.
“Angioplasty is an effective procedure, but it carries risks,” Knight said in prepared remarks. “My goal is to develop a noninvasive alternative to angioplasty.”
Medtronic Inc. (NYSE:MDT) tapped veteran British interventional cardiologist Martin Rothman to lead a portion of its vascular business.
The Minneapolis medical device monolith said Rothman will be vice president of medical affairs for its Santa Rosa, Calif.-based coronary and peripheral vascular business, effective Jan. 4. He spent the last 37 years in clinical practice at the London Chest Hospital, where he directed cardiac research and development for the past 10 years.
Philips bids on ultrasound-guided gene therapy: Delivering DNA sequences to cells for gene therapy is already being investigated, with the current approaches relying on viruses and smart nanoparticles as vectors for gene transfer. But Philips and GlyGenix Therapeutics, out of Woodbridge, Conn., plan on taking another approach, hoping that the large molecules can be pushed to their destination using ultrasound. Specifically, the pre-clinical trials will study the technology, known as ultrasound-mediated plasmid DNA (pDNA) delivery, on Glycogen Storage Disease Type 1a (GSD-1a) that exhibits a defective G6Pase gene.